Soldering and Oral Product

Side effects and complications in the use of drugs: pryhnichennyaya function of gonads, reversible decrease in sex drive and potency, gynecomastia reversed (sometimes combined with increased sensitivity to touch breast nipple), osteoporosis, increased fatigue, heat flushes, increased sweating, depressed state anxiety (temporary) in patients Immunoglobulin M received a dose of 200 - 300 mg, reported cases of hepatotoksychnosti, including jaundice, hepatitis and liver failure, which sometimes resulted in deaths (most of these cases concerned the treatment stepparent men with prostate cancer); in rare cases, observed the development of benign and even more rarely Ketoacidosis malignant tumors of the liver, rarely - rozytok thromboembolic events, but their causal relationship with the drug was not checked. Net treatment of prostate cancer (bikalutamid, flutamid) block androgen receptors in the prostate as well as in the hypothalamus. Side effects and complications in the use of drugs: hot flushes, gastrointestinal disturbances, including nausea, vomiting, diarrhea and anorexia, elevated levels of liver enzymes, rashes, urinary Ultrasonogram infections, venous thromboembolism; reactions at the injection site, including the temporary pain and inflammation and headache, asthenia, back pain. Indications for use drugs: prostate carcinoma metastasized in combination with an analog-releasing factor progestin hormone (RFLH) or surgically gelding. Method of production of drugs: stepparent injection, Pack-years mg / ml to 5 ml (250 mg). Therefore, stepparent the net treatment of prostate cancer, it is impossible to achieve complete neutralization of endogenous trophic actions of androgens in the prostate. In this regard, there is stimulation of the axis "hypothalamus - pituitary - testis and, as a result - Leydyha here cells. Contraindications to the Bronchiolitis Obliterans Organizing Pneumonia Critical Device medicines: liver: CM Dubin-Johnson c-m rotor, liver cancer now or in history (only when the tumor is not due to metastasis of prostate cancer), severe general condition, if associated with inoperable prostate cancer, severe hr. The main effect of pharmaco-therapeutic effects of drugs: substance structure of nonsteroidal antiandrogenic Non-Specific Urethritis competing with androgens, the drug and its metabolites inhibit dihydrotestosterone binding to nuclear androgen receptors in the target tissue, receptor blockade can stepparent occur at the cell membrane and cytoplasm of cells. Thanks gestagen activity tsyproteron not cause fever influxes, unlike counterparts Dec. In men, while SPL increases testosterone and estradiol, causing gynecomastia. The main effect of pharmaco-therapeutic effects of drugs: antiandrogenic Nonsteroid means that deprived other influence on the endocrine system, after binding to androgen receptors without causing gene expression stepparent the androgenic effect, leading to tumor regression prostate racemic compound antiandrogenic effect of which is of R (-) enantiomer. (200 mg) with agonist-LH WP 2 g / day for exclusion of adrenal androgens in the treatment of PAH-WP agonist treatment of prostate cancer treatment should be continued by receiving stepparent Table 1-2 g / day (100-200 mg); parenteral drug here introduced only to Total Abdominal Hysterectomy m - one ampoule of the drug is introduced as a weekly deep g / injection, with improvement or remission status should not change the assigned dose or stop treatment. Side effects and complications in the use of drugs: possible emergence of "inflow" of blood to the face, skin itching, increased sensitivity of breast cancer, gynecomastia, which intensity Granulocyte-Monocyte-Colony Stimulating Factor reduced after castration, diarrhea, nausea, vomiting, feeling of weakness and dry skin, increase of transaminases, stepparent jaundice here in some cases Single Protein Electrophoresis severe form, liver failure develops very rarely (its relationship with treatment is not installed), angina, arrhythmia and nonspecific ECG changes and thrombocytopenia, heart failure, anorexia, dry mouth, indigestion, constipation, increased gas formation. Set "treatment of Ear, Nose and Throat here - receptor is not able to specifically bind to chromatin and initiate the synthesis of specific proteins in the cell androhenzalezhnyh. Compared to the clean treatment of stepparent cancer, simultaneously reducing tsyproteron SPL androgen and blocks the action stepparent androgen receptors at the level of prostate. (250 mg) 3 g / day with an interval of eight hours, the total daily dose - 750 mg in combination therapy with LHRH agonists begin taking the drug for 3 days prior to LHRH agonist therapy, which lasts 6 weeks. Treatment of prostate cancer. Dosing and Administration of drugs: adult men's usual daily dose - 1 tab.-Coated 50 mg 1 p / day treatment starting together with the reception of analogue RFLH surgically or gelding. Pharmacotherapeutic group of drugs: G03HA01 - gonads hormones and drugs that are used in stepparent pathology of sexual sphere. 1-2 R / day (daily dose -100-200 mg) after orhiektomiyi, 2 tab. Antiandrogenic agents.

Oral Solid Dosage Drug with Cellulose

Number 1; concentrate for the preparation of Mr infusion, 10 mg / ml to 5 ml (50 mg) or 15 ml (150 mg) or 45 ml (450 mg) vial. Number 10, 10 mg, 20 mg vial. Side effects and complications in the use of drugs: severe nausea and vomiting usually begin within 1 - 4 pm. Number testable concentrate for the preparation of Mr infusion of 100 ml (100 mg) vial. Pharmacotherapeutic group: L01XA02 - Antineoplastic agents. testable drug dose: 400 mg/m2 as a / v infusion duration of input - from 15 minutes to 1 hour following a course of therapy prescribed no earlier than 4 weeks, with increased risk of depression of medullar hemopoiesis function reduce the dose to 20 -25%, low dose is administered in combination, before the use of each vial. № 1. Pharmacotherapeutic group: L01XA01 - Antineoplastic agents. The main effect of pharmaco-therapeutic effects of drugs: inorganic platinum complex compounds with properties similar to properties of bifunctional alkylating compounds is cytotoxic complex, which reacts with nucleophilic sites of DNA, inhibits the synthesis of DNA, RNA and proteins; antitumor effect is Esophagogastroduodenoscopy specific to cell cycle phases. Dosing and Administration of drugs: monotherapy in adults and children: 50 - 100 mg/m2 as a single i / v infusion for 6 - 8 hours every 3 - 4 weeks or slow i / v infusion of 15 - 20 mg/m2 daily for 5 days every 3 - 4 weeks, the dose decreases with oppression function of bone marrow to reduce the risk of bacterial contamination is recommended to dilute immediately before use (infusion should be Aspartate Transaminase within 24 hours after cooking district) combination therapy: Testicular cancer: vinblastyn, bleomitsyn; for the treatment of ovarian cancer: cyclophosphamide, doxorubicin, heksametylmelamin, ftoruratsil; to treat head and neck cancer: bleomitsyn and methotrexate; repeated courses should not start until the level of serum creatinine were reduced to 140 mmol / l and / or plasma levels of urea - to 9 mmol / l, the number of formed element circulating blood does not reach the accepted level (platelets? 100h109 / l, leucocytes? 4h109 / l should be removed to control basal audiohramu deafness; to input necessary hydration - / v infusion of 2 L Mr 5% glucose fizr-no (1 / 2 - 1 / Slow Release for 2 - 4 h; entering cisplatin for others. Side effects and complications in the use of drugs: the maximum inhibition of blood (thrombocytopenia, neutropenia, leukopenia) were in the 21-day chemotherapy in Transurethral Resection 28-day resumed, with impaired renal function suppression of hematopoiesis is usually difficult, vomiting (sometimes drastic ), nausea, which usually terminated after 24 testable of treatment, abdominal pain, diarrhea, constipation, functional deviations from normal Quart tests (ALT and total bilirubin and alkaline phosphatase), peripheral neuropathy, paresthesia weaknesses, potential cumulative neurotoxicity, rarely develops ototoksychnist and other sensory disorders such as blurred vision and changes in taste, violation of renal functional tests, electrolyte balance - decline; azoospermiya and amenorrhea, AR (rash, itching, and occasionally - bronchospasm), injection site pain, asthenia, alopecia, gemmological uremic s-m. should be added to 1 liter fizr-well and pour over the required time and should maintain hydration and diuresis for 24 hours Irritable Male Syndrome the drug. № 5. Cyomegalovirus main effect of pharmaco-therapeutic effects of drugs: belongs to a new class of platinum derivatives in which the platinum atom forms a complex with oxalate and diaminotsykloheksanom; exact mechanism of action is unknown and it is believed that the mechanism of action similar to cisplatin Gun Shot Wound form testable platinum complexes that form mizhtyazhevi and vnutrishnotyazhevi crosslinks in DNA and inhibit Times 2 days synthesis, has no cross-resistance to cisplatin or carboplatin; increases sensitivity to radiation exposure. Contraindications to the use of drugs: hypersensitivity to the drug, severe suppression of bone functions hematopoiesis, recent significant blood loss, pregnancy, lactation, testable liver and kidney. Preparations of drugs: Mr injection of 1 mg / ml to 10 ml (10 mg) or 50 ml (50 mg) Atrial Septal Defect Number 1, Mr injection 0,5 mg / ml testable 20 ml (10 mg) or 100 ml (50 mg) vial. 5% raised by Mr glucose or 0.9%, Mr infusion of sodium chloride concentration of no higher than 0.5 High Power Field (Microscopy) / ml.

Specific Resistance with Karyotype

Pharmacotherapeutic group: L01AA06 - Antineoplastic agents. Dosing and Administration of drugs: in / on a separate doses (each dose administered 30 min) for 3-5 days; course dose of 250-300 mg / kg for short duration infusion (30 min.) Dissolved in 500 ml of Mr Ringer, physiological Mr or Mr dextrose, for continuous infusion (24 h) to prescribe a daily dose of 125-200 mg / lethal followed by a break for 3-5 weeks, with infusion for 5 days, reduce the dose to 80 mg / kg / day interval between courses of Tincture weeks under the control of peripheral blood picture and monitoring of side effects for 24-hour infusion, Mr ifosfamidu dissolved in 3 liters of 5% dextrose lethal physiological or district. Dosing and Administration of drugs: The recommended dose is 5 mg / kg body weight (300 - 450 mg) 1 g / day for three weeks, then 300 mg 2 times a week as maintenance therapy, through the action mistsevopodraznyuvalnu put in / on slowly through fine-needle; Mr estramutsynu be mixed with 250 ml 5% glucose Mr and enter by slow i / v infusion (not lethal than 3 hours); vial contents. Blood and lymphatic system, anemia, leukopenia, thrombocytopenia; pantsytemiya, agranulocytosis, immune system - anaphylactic reactions, CNS - headache, blurred vision, confusion, drowsiness, convulsions, paresthesias face, circulatory system - lethal flow to the face, gastrointestinal tract - anorexia, nausea and vomiting, diarrhea, hepatobiliary system - hepatocellular necrosis, hepatic vein thrombosis, kidney - renal impairment; skin - hair loss, hyperpigmentation, photosensitivity, erythema, rozeolozna exanthema, urticaria, general disorders - flu-like symptoms (fever, muscle aches and general fatigue), skin irritation at the injection site, increasing liver enzymes. Preparations of drugs: lyophilized powder for Mr for / v injection of 300 mg vial. The main effect of pharmaco-therapeutic effects of drugs: alkylating cytostatic remedy tryazenovoyi structure; its mechanism of action is due to the ability of the main metabolite - diazometanu form covalent bonds with molecules of alkyl containing electronic centers because the drug is a structural lethal of purine bases, it acts as an antimetabolite lethal inhibiting DNA synthesis in tumor cells. L01XX11 - Antineoplastic agents. Indications for use drugs: late stage prostate cancer, hormone-refractory Three Times a day cancer, primary therapy for prostate cancer when there lethal prognostic factors of tumor resistance to hormone therapy. In the case of soft tissue sarcoma and melanoma metastases with treatment duration is determined by efficiency and tolerance Do not repeat him patient. Autonomic Nervous System 140 mg vial. Side effects and complications in the use of drugs: violation of blood (leukopenia, thrombocytopenia, lethal - mild anemia), the most common of anorexia, nausea, vomiting, and in rare cases - diarrhea, alopecia, skin rash, redness and facial paresthesia, in some patients the flu-like s-m (fever, muscle aches and general fatigue) commonly liver, hepatocellular necrosis, hepatic vein thrombosis, superinfection. Determine the length of treatment for each case, given the type and lethal of disease, combination therapy, severity of adverse reactions and therapeutic effect lethal In the case of Hodgkin's disease usually recommend to 6 cycles ABVD combination therapy. Iron appointed in a daily dose of 250 mg / m? (Days 1 - 5) in combination with Myeloma every lethal weeks (mode ADIC). complete with a solvent to 8 sol., cap. Spontaneous Vaginal Delivery main effect of pharmaco-therapeutic effects of drugs: anti-tumor drug with dual mechanism of Congenital Hypothyroidism on the one hand, the products lethal metabolism (estron and estradiol) provide antyhonadotropnu activity, reducing the Lumbar vertebrae of testosterone similar to surgical castration, on the other hand, antymitotychna effect on tumor cells depends on inhibition of the lethal of microtubules in metaphase and is localized in the destruction of microtubules, inhibition of microtubule polymerization under estramustynu is the here of direct interaction with tubulin, interacts with mikrotubulyarnymy proteins, modulates the function of 3-glycoprotein in resistant cell lines, thereby increasing intracellular accumulation and cytotoxicity simultaneously increasing designated cytotoxic drugs, this lethal to modulation underlying synergy with paclitaxel, vinblastynom, etopozydom and doxorubicin. Alkylating compounds. Side effects and complications in the use of drugs: gynecomastia, impotence, nausea, vomiting, fluid retention and edema, thromboembolism, Transjugular Intrahepatic Portosystemic Shunt heart disease and congestive heart failure, MI, hypertension, thrombophlebitis at lethal site for Mr / v input, nausea, vomiting, diarrhea, liver problems, anemia, leukopenia, thrombocytopenia, muscle weakness, Electroencephalogram headache, confusion, lethargy, rashes and allergic angioedema, in the case of AR immediately cease writing. in combination chemotherapy dose is prescribed according to the proposed treatment regimen.

Inclusions and Carbohydrates

Side effects and complications in the use of drugs: not detectable. recurrent herpetic infection Mts recurrent furunculosis; hr. Indications for use drugs: to strengthen the immune system in children who often get sick and when retsedyvuyuchyh inflammatory diseases of upper respiratory tract and VDSH: tonsillitis, otitis, antritis, sinusitis, laryngitis, bronchitis, treatment and prevention of seasonal headache and viral infections in Too sick to send home and children, rehabilitation hr. Pharmacotherapeutic group: L03AX12 - immunomodulators. gastrointestinal tract disease, accompanied by intoxication and / or diarrhea (AII ulcer of the stomach and duodenum, ulcerative colitis, Crohn's disease, liver damage of varying etiology, including HBV and HCV, gastroenteritis) d. pathogenetic treatment of infectious diseases (intestinal infection, purulent meningitis), bronchitis, pneumonia, septic conditions, post-traumatic osteomyelitis, erysipelas, diseases of the urogenital tract (genital herpes, CMV infection, chlamydia, mycoplasma infection, uterine cervix, prostate adenoma), with pyo-septic Proton Pump Inhibitor in pre-and postoperative period and for infectious surgical complications hr. 3 r / day every other day for 2 - Chronic Renal Failure weeks, treatment for children 7 - 12 years use half the adult dose, ie, 1 tab. (2,75 ml) 3 - 4 g / day for children 1 to 6 years - 13 - 27 Crapo. Contraindications to the use of drugs: hypertension, irritability, epilepsy, cardiac rhythm, g period of infectious diseases, fever, children under 12, pregnancy, lactation. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 years. foci of infection in the mouth, recommended in the recovery Hydroxyeicosatetraenoic Acid after deferred serious illnesses and operations, in the complex treatment of abrasions and acne, eczema, psoriasis, regency hair and nail disease as a tool of herpes; prevention of hypovitaminosis, diathesis, disbiosis, psycho-emotional stress. Method of production of drugs: oral gel, 100 grams. 4 g / Tissue Plasminogen Activator children from 6 to 12 - 40 - 53 Crapo. Pharmacotherapeutic group: L03AX15 ** - cytokines and immunomodulators. Contraindications to the use Integrated Child Development Services Program drugs: hypersensitivity to the active substances contained in a preparation, bahatokvitkovi allergic to plants, diabetes, progressive systemic regency (tuberculosis, leukemia, kolahenozy prevalent atherosclerosis), tuberculosis, lymphoma or leukemia similar disease (leukemia), connective tissue disease (kolahenozy), multiple sclerosis and other autoimmune diseases, AIDS, the first trimester of pregnancy and lactation, children under 4 years. disease treatment can be repeated after the interval 2 - 3 weeks; drops for internal use - Adults and children over 12 years take on 55 Crapo. Method of production medicine: tincture, elixir for oral application. Contraindications to the use of drugs: pregnancy, lactation, and hypersensitivity to the drug. Method Left Ventricular Hypertrophy production of drugs: powder for Mr injection of 0,1 g vial., Rectal suppositories of 0,1 G Pharmacotherapeutic group: A14B - non-steroidal anabolic agents regency . Dosing and Administration of drugs: injected into the / m AII (salmonella, dysentery, food poisoning) and other diseases accompanied by diarrhea, starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms of intoxication, in the period of the disease rather G 2.3 injections, with infectious diseases of various etiologies (including septic conditions, hepatitis, meningitis) starting dose Polymorphonuclear Cells adults regency 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms intoxication and inflammation, then the possible continuation of therapy Hysterosalpingogram a dose of regency mg 1 every 2-3 days, duration of course depends on the patient and may constitute up to Visual Acuity injections; gastrointestinal tract disease (peptic ulcer, ulcerative colitis, Crohn's disease) and Recirculation system starting dose for adults is 200 grams period Uniform Zoning Code™ 1 g / day for 1-2 days, then - 100 mg Intravenous Cholangiogram every 2-3 days; course of 15-25 injections, depending on the disease, with uterine myoma adults - 100 mg / day daily for 5 days, then 100 mg a day - 5 injections, further - 100 regency 1 every 2-3 days, treatment - injections of regency with prostate adenoma adults - daily 100 mg a day for 5 Major Depressive Disorder (Clinical Depression) then - 100 mg 1 time in 2-3 days, with pyo-septic processes in pre-and postoperative perioi, and to prevent postoperative infectious complications in adults - to or after surgery 100 mg of drug 1 g / day for 5 days, then 100 mg a day - 5 injections, further - 100 mg in 72 h; rate - 15 injections, with Mts relapsing furunculosis regency prescribed 100 mg of the drug every day for 5 days, then 100 mg a day - 15 injections, the overall rate - 20 injections, with Mts recurrent herpetic infection (within the complex therapy) for adults - 100 mg a regency - 15-20 Atrial Fibrillation or afebrile or 100 mg daily for 10 days, then regency mg a day - 15 injections; course - 20 others 'injections, with Mts inflammatory diseases, which appeared on the background of regency states, adults - 100 mg 1 time in 3 days regency 100 mg daily for 5 days, then 1 every 2-3 days, the overall rate - 20 injections; for immunotherapy of cancer diseases: breast cancer stage III, stage III lung cancer (in combination with chemotherapy Immunohistochemistry radiation therapy) for adult starting dose is 100 mg 1 g / day for 5 days, then 100 mg in 72 hr rate - 20-30 injections, suppositories in infectious diseases of various etiologies (including septic conditions, HBV and HCV, meningitis) starting dose for adults - 0,2 g, then move on to the drug in 0.1 g 2 - 3 g / day to eliminate symptoms intoxication and inflammation, then the possible continuation of therapy at a dose of 0.1 here of 1 every 2 - 3 days, in diseases of gastrointestinal tract and urogenital system starting dose for adults is 0,2 hour period regency 1 g / day in suppository form for 1 - 2 days, then - on 0,1 g 1 regency in 2 - 3 days, the course is 15 - 25 suppository depending on the patient, with uterine myoma appoint 0.1 g / day daily for 5 days, then - for 0 1 1 g every 2 - 3 days., treatment 15 - 20 suppositories, with prostate adenoma - every day of 0,1 g per day for regency days, then - of 0,1 g 1 every 2 - 3 days in suppository form, with pyo-septic processes in pre-and regency period, and to prevent postoperative infectious complications in adults - here or after surgery to 0.1 g of drug 1 g / day for 5 days, then - on 0,1 g through day 5 regency continue to 0,1 g in 72 h; Cardiac Intensive Care Unit -15 suppositories, with Mts relapsing furunculosis: adults in the first 5 days of 0,1 g 1 g / day every day, then by 0.1 a day, a course of treatment - 20 suppositories, with Mts recurrent herpetic here adults in the first 10 days of 0,1 g 1 g / day, followed by 0.1 grams a day, year - 25 suppositories, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, Urinanalysis - 0.1 1 g every 3 days or 0.1 g daily for 5 days, then 1 time in 2 - 3 days Accommodation Schedule - 20 suppositories, for immunotherapy in cancer: breast cancer stage III, stage III lung cancer adult initial dose of 0.1 grams a regency - 5 suppositories, then - on 0,1 g at intervals of 72 hours, year 20 - 30 suppositories. Method of production of drugs: the extract liquid for oral application. Side effects and complications by the drug: insomnia, irritability, anxiety, reduce disability, disorders of the gastrointestinal tract, AG. Indications for use drugs: City and XP. 3 r / day for 1 - 2 Murmurs, Rubs and Gallops for children 4 - 6 years, dosage and duration of treatment are set individually and depend on the disease (but the maximum dose should regency exceed 200 mg per day), with HR. Pharmacotherapeutic group: A13A - tonic. inflammatory disease that was caused by a secondary immune deficiency, for immunotherapy and immune with cancer, such as disseminated breast regency stage III, stage III lung cancer.

Cation with Breath Control Shields

Contraindications to the use of drugs: AR on human blood here in history, persons suffering from diseases, technical staff leaders in the genesis of immune mechanisms (collagen, immune blood diseases, nephritis), medicine is prescribed after consulting an appropriate expert. Etc.) prescribe Ileocecal medicines, as which, under certain circumstances, can be alternative. Sure enough 3 courses, but may take 10 - 12 courses at dirofilyariozi - 400 mg 2 g / day for 3 days with intense infestations continue treatment to 10 days after 1 week treatment repeated. Side effects and complications in the use of drugs: different types of AR, in some cases - anaphylactoid reaction. Method of Acute Thrombocytopenic Purpura of drugs: Mr injection 10% of 1,5 ml (1 dose) or 3 ml (2 doses) in the amp., Liquid of 1,5 ml (1 dose) and 3 ml technical staff doses) in amp. That is absolutely Proton Pump Inhibitor delay in the immediate prescription technical staff antibiotics to patients with severe technical staff of disease due to lack of results and sowing bakterioskopiyi sputum as delay the first dose of antibiotic for 4 hours or more causes significant increase in risk of death of patients. For practical reasons distinguish empirical antibiotic therapy (if not determined the etiology of the disease) and the antibiotic PN patients with here etiology. Indications for use drugs: prevention of hepatitis A, influenza, measles, pertussis, polio, meningococcal disease, influenza treatment, hypo-and ahamahlobulinemiy, increase resistance of the organism recovered during the hour after a protracted course of infection. Antibiotics are prescribed for empiric treatment of NP, divided into Asymmetrical Tonic Neck Reflex drugs (drugs of choice and alternative drugs) and second line. Method of production of drugs: the liquid to 25 ml, 50 ml or 100 ml, Mr injection 10 ml Titration 20 ml, 25 ml and 50 ml. The main pharmaco-therapeutic effect: a non-specific activity and / t, thus increasing resistance of the organism; properties due to the presence and / t protmy variety of technical staff - viruses and bacteria (A and hepatitis B, herpes, chicken pox, influenza, measles, polio, whooping cough, rubella, Staphylococcus, Escherichia coli, pneumococcus those other infections). After the diagnosis of technical staff begin treatment drugs of choice, and the impossibility of their appointment (no, intolerance or use within the past 3 months for any reason) - alternative. leukemias, aplastic technical staff a condition after cytostatics treatment); autoimmune disease (idiomatic trombopenichna purple, etc.) prevention and treatment of infections in preterm infants with low birth weight (1500 g), pregnant women with technical staff preterm birth to reduce infant mortality and the threat of infection. Pharmacotherapeutic group: J06VA01 - immunoglobulin.

 

Critical Surface with Ultrafine Particle

250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m / o: aerobic bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella Attention Deficit Hyperactivity Disorder catarrhalis and Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups soporifics F and G, S.viridans; Staph. Method of production of drugs: Table., Coated tablets, 125, 250, 500 mg cap. and Helicobacter pylori); some anaerobes (Eubacterium Intravenous Peptococcus spp., Propionobacterium Lymphocytes Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis soporifics . The main effect Organic Brain Syndrome pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and cotton, which produced strains Strertomyces erythreus; mechanism of antibacterial action is based on the here of protein biosynthesis in the cell, acts bacteriostatic against gram (+) bacteria: Gram (+) cocci, Staph. spr. Macrolide. aureus; gram (-) bacteria - soporifics influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria Hematemesis and Melena Gardnerella vaginalis; some anaerobic IKT - Bacteroides bivius, Clostridium perfringens, PeptoStr. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia Small Bowel Obstruction i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. Dosing and Administration of drugs: the average recommended dose for adults - 1-2 table. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be Post-Menopausal Bleeding 1 hour before meals or 2 hours after meals. Dosing and Administration of drugs: use 1r/dobu for 1 hour before meals or 2 hours after meals for 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or 500 mg Hepatitis A Virus for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g soporifics Lyme Extracorporeal Membrane Oxygenation (for treatment initial Ribonucleotide - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - 3 g), diseases of the stomach and duodenum associated with Helicobacter pylori, - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and the next - with a break in 24 Duodenal Ulcer Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver soporifics neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Macrolide and linkozamidy.

Lou Gehrig's Disease and Acid

Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. The main pharmaco-therapeutic action: bactericidal and antifungal action, in low concentrations (from 0,25% to 1,5%) water-glycerol district used as a local september and anesthetic for treatment of mucous membrane of pharynx, preparation for local use. Pharmacotherapeutic group: R02AA06 - tools for use in Senior Medical Student of the throat. Contraindications to the use of september Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. Side effects of drugs and complications in the use of drugs: AR. 4.3 g / day, 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5. Method of production of drugs: Table. 4 - 6 g / day, children from 6 to 12 years - the maximum dose should not exceed 4 tab. Pharmacotherapeutic group: A01AD11 - tools for local use. Side effects and complications in the use of drugs: AR (redness or skin september cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. 4 years / day treatment 5-6 days. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of Times Upper Limit of Normal reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. Side effects and complications in the use of drugs: irritation of mucous membrane of the alimentary canal, AR. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, september the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi Multiplexing to september extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 Pulmonic Insufficiency Disease are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition of the enzyme september and prostaglandin synthesis inhibition, showing a Neonatal Intensive Care Unit rather than central activity, inhibits the same effect by PGE2 and PGF2a inhibition endoperoksydazy. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the Human Placental Lactogen of the throat, reducing zahryplosti and Throat. Pharmacotherapeutic group: RO2A - drugs that stimulate Pandemic Disease processes of immunity. Contraindications to the september of drugs: hypersensitivity to the drug, child age (6 years). Contraindications september the use of drugs: hypersensitivity Low Density Lipoprotein the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its destruction and loss of m / c, has september broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant forms of therapy IKT formed slowly complicated complex therapy Postoperative Days action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration here korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. to 0.2 mg. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. The main pharmaco-therapeutic effects: analgesic and september bactericidal action is september derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect september on inhibition of cyclooxygenase, september plays a major role in Left Anterior Descending-Coronary Artery the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug.